Subcutaneous cytosine arabinoside is superior to intravenous route in remission maintenance therapy of acute myelocytic leukemia

K. R. Rai, O. Glidewell, O. R. McIntyre, J. F. Holland

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)No. C-478
JournalProceedings of the American Association for Cancer Research
VolumeVol. 20
StatePublished - 1979
Externally publishedYes

Cite this